Frontiers Lysosomal Diseases and Neuropsychiatry: Opportunities

Por um escritor misterioso
Last updated 15 janeiro 2025
Frontiers  Lysosomal Diseases and Neuropsychiatry: Opportunities
Frontiers  Lysosomal Diseases and Neuropsychiatry: Opportunities
Frontiers NEU1—A Unique Therapeutic Target for Alzheimer's Disease
Frontiers  Lysosomal Diseases and Neuropsychiatry: Opportunities
Frontiers Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches
Frontiers  Lysosomal Diseases and Neuropsychiatry: Opportunities
The Possible Involvement of Autophagy in Neuropsychiatric Disorders and Their Treatment
Frontiers  Lysosomal Diseases and Neuropsychiatry: Opportunities
Frontiers Ubiquitination-Dependent Regulation of Small GTPases in Membrane Trafficking: From Cell Biology to Human Diseases
Frontiers  Lysosomal Diseases and Neuropsychiatry: Opportunities
JCM, Free Full-Text
Frontiers  Lysosomal Diseases and Neuropsychiatry: Opportunities
Frontiers The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?
Frontiers  Lysosomal Diseases and Neuropsychiatry: Opportunities
FDA approved compounds for lysosomal storage disorders, endpoints and
Frontiers  Lysosomal Diseases and Neuropsychiatry: Opportunities
Frontiers Vesicular Dysfunction and the Pathogenesis of Parkinson's Disease: Clues From Genetic Studies
Frontiers  Lysosomal Diseases and Neuropsychiatry: Opportunities
Frontiers Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through

© 2014-2025 trend-media.tv. All rights reserved.